High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$25K
$25,052
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
NTLA
S
Intellia Therapeutics, Inc.
BASTA JAMES
• Officer • EVP, General Counsel
Sell to Cover
2026-03-02
$16,688
|
||||||
| NTLA |
Intellia Therapeutics, Inc.
|
Officer • EVP, General Counsel
Sell to Cover
|
2026-03-02 | $16,688 | S | Form 4 |
|
NTLA
S
Intellia Therapeutics, Inc.
Clark Eliana
• Officer • EVP, Chief Technical Officer
Sell to Cover
2026-03-02
$8,364
|
||||||
| NTLA |
Intellia Therapeutics, Inc.
|
Officer • EVP, Chief Technical Officer
Sell to Cover
|
2026-03-02 | $8,364 | S | Form 4 |